CTMX vs SMFG
CytomX Therapeutics Inc (CTMX) versus SMFG (SMFG) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
SMFG (SMFG) common stock.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
SMFG does not have a complete income-statement cache yet.
CTMX currently screens at market cap $653.1M. SMFG currently screens at market cap $0.
Not investment advice. Open the CTMX and SMFG stock pages for the full models.
Not investment advice.